The World Health Organization (WHO) has validated Senegal as having eliminated trachoma as a public health problem. Senegal becomes the ninth country in WHO’s African Region to have achieved this feat.
“I commend Senegal for freeing its population from this disease”, said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “This milestone is yet another sign of the remarkable progress being made against neglected tropical diseases globally, and offers hope to other countries still working to eliminate trachoma.”
Trachoma has been known in Senegal since the early 1900s and was confirmed as a major cause of blindness through surveys in the 1980s and 1990s. Senegal joined the WHO Alliance for the Global Elimination of Trachoma in 1998, conducted its first national survey in 2000, and completed full disease mapping by 2017 with support from the Global Trachoma Mapping Project and Tropical Data. Trachoma control was consistently integrated into national eye health programmed, first under the National Program for Blindness Prevention (PNLC) and later through the National Program for the Promotion of Eye Health (PNPSO) – maintaining its commitment to trachoma elimination.
“Today we celebrate our victory against trachoma, 21 years after the one against dracunculiasis” said Dr Ibrahima Sy, Senegal’s Minister of Health and Social Action. “This new milestone reminds us that our overarching goal remains a Senegal free from neglected tropical diseases. We are fully committed to this, and we are making good progress, notably against human African trypanosomiasis (sleeping sickness) and onchocerciasis”.
Senegal implemented the WHO-recommended SAFE strategy to eliminate trachoma with the support of partners, reaching 2.8 million people who needed them across 24 districts. These activities included provision of surgery to treat the late blinding stage of the disease, conducting antibiotic mass drug administration of azithromycin donated by Pfizer through the International Trachoma Initiative, carrying out public awareness campaigns to promote facial cleanliness, and improvement in access to water supply and sanitation.The World Health Organization (WHO) has validated Senegal as having eliminated trachoma as a public health problem. Senegal becomes the ninth country in WHO’s African Region to have achieved this feat.
“I commend Senegal for freeing its population from this disease”, said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “This milestone is yet another sign of the remarkable progress being made against neglected tropical diseases globally, and offers hope to other countries still working to eliminate trachoma.”
Trachoma has been known in Senegal since the early 1900s and was confirmed as a major cause of blindness through surveys in the 1980s and 1990s. Senegal joined the WHO Alliance for the Global Elimination of Trachoma in 1998, conducted its first national survey in 2000, and completed full disease mapping by 2017 with support from the Global Trachoma Mapping Project and Tropical Data. Trachoma control was consistently integrated into national eye health programmed, first under the National Program for Blindness Prevention (PNLC) and later through the National Program for the Promotion of Eye Health (PNPSO) – maintaining its commitment to trachoma elimination.
“Today we celebrate our victory against trachoma, 21 years after the one against dracunculiasis” said Dr Ibrahima Sy, Senegal’s Minister of Health and Social Action. “This new milestone reminds us that our overarching goal remains a Senegal free from neglected tropical diseases. We are fully committed to this, and we are making good progress, notably against human African trypanosomiasis (sleeping sickness) and onchocerciasis”.
Senegal implemented the WHO-recommended SAFE strategy to eliminate trachoma with the support of partners, reaching 2.8 million people who needed them across 24 districts. These activities included provision of surgery to treat the late blinding stage of the disease, conducting antibiotic mass drug administration of azithromycin donated by Pfizer through the International Trachoma Initiative, carrying out public awareness campaigns to promote facial cleanliness, and improvement in access to water supply and sanitation.The World Health Organization (WHO) has validated Senegal as having eliminated trachoma as a public health problem. Senegal becomes the ninth country in WHO’s African Region to have achieved this feat.
“I commend Senegal for freeing its population from this disease”, said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “This milestone is yet another sign of the remarkable progress being made against neglected tropical diseases globally, and offers hope to other countries still working to eliminate trachoma.”
Trachoma has been known in Senegal since the early 1900s and was confirmed as a major cause of blindness through surveys in the 1980s and 1990s. Senegal joined the WHO Alliance for the Global Elimination of Trachoma in 1998, conducted its first national survey in 2000, and completed full disease mapping by 2017 with support from the Global Trachoma Mapping Project and Tropical Data. Trachoma control was consistently integrated into national eye health programmed, first under the National Program for Blindness Prevention (PNLC) and later through the National Program for the Promotion of Eye Health (PNPSO) – maintaining its commitment to trachoma elimination.
“Today we celebrate our victory against trachoma, 21 years after the one against dracunculiasis” said Dr Ibrahima Sy, Senegal’s Minister of Health and Social Action. “This new milestone reminds us that our overarching goal remains a Senegal free from neglected tropical diseases. We are fully committed to this, and we are making good progress, notably against human African trypanosomiasis (sleeping sickness) and onchocerciasis”.
Senegal implemented the WHO-recommended SAFE strategy to eliminate trachoma with the support of partners, reaching 2.8 million people who needed them across 24 districts. These activities included provision of surgery to treat the late blinding stage of the disease, conducting antibiotic mass drug administration of azithromycin donated by Pfizer through the International Trachoma Initiative, carrying out public awareness campaigns to promote facial cleanliness, and improvement in access to water supply and sanitation.
